27 Jun 2022 Trastuzumab Deruxtecan Recommended for Approval in the EU by CHMP for Patients with HER2 Positive Metastatic Breast Cancer Treated with a Prior Anti-HER2-Based Regimen Press Releases
27 Jun 2022 US FDA Approves Prestige Biopharma’s IND for Phase 1/2a Trial of First-in-Class Pancreatic Cancer Treatment, PBP1510 Press Releases SINGAPORE–(…
27 Jun 2022 European Academy of Neurology (EAN 2022) – Braintale to Present Promising Results on Amyotrophic Lateral Sclerosis Biomarker Potential of Its Digital Platform Press Releases
27 Jun 2022 Results from Phase 2 Study of Fazirsiran in Patients with Alpha-1 Antitrypsin Deficiency Published in New England Journal of Medicine Press Releases OSAKA,…
27 Jun 2022 BiomX Announces Dosing of the First Two Patients in Phase 1b/2a Study of BX004 for Treatment of Chronic Respiratory Infections in Patients with Cystic Fibrosis Press Releases
27 Jun 2022 SwanBio Presents Design of Innovative Natural History Study Aimed to Evolve Understanding of Adrenomyeloneuropathy and Inform Future Treatments Press Releases
27 Jun 2022 BWXT Medical Executes Commercial Agreement with Bayer for Supply of Actinium-225 Based Products Press Releases …